| 6V4I 
   
  | | DanD |  | Descriptor: | DanD peptide |  | Authors: | Hoang, H.N. |  | Deposit date: | 2019-11-27 |  | Release date: | 2020-12-02 |  | Last modified: | 2024-10-16 |  | Method: | SOLUTION NMR |  | Cite: | DanD To Be Published
 
 | 
 | 
| 6V4T 
   
  | | MPER-TMD of HIV-1 Env bound with the entry inhibitor S2C3 |  | Descriptor: | 4,4'-(decane-1,10-diyl)bis(9-amino-2,3-dihydro-1H-cyclopenta[b]quinolin-4-ium), Envelope glycoprotein gp160 |  | Authors: | Xiao, T,  Frey, G,  Fu, Q,  Lavine, C.L,  Scott, D.A,  Seaman, M.S,  Chou, J.J,  Chen, B. |  | Deposit date: | 2019-11-30 |  | Release date: | 2020-04-01 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR |  | Cite: | HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes. Nat.Chem.Biol., 16, 2020
 
 | 
 | 
| 6V5D 
   
  | | EROS3 RDC and NOE Derived Ubiquitin Ensemble |  | Descriptor: | Ubiquitin |  | Authors: | Lange, O.F,  Lakomek, N.A,  Smith, C.A,  Griesinger, C,  de Groot, B.L. |  | Deposit date: | 2019-12-04 |  | Release date: | 2020-01-01 |  | Last modified: | 2024-05-01 |  | Method: | SOLUTION NMR |  | Cite: | Enhancing NMR derived ensembles with kinetics on multiple timescales. J.Biomol.Nmr, 74, 2020
 
 | 
 | 
| 6V5L 
   
  | | The HADDOCK structure model of GDP KRas in complex with its allosteric inhibitor E22 |  | Descriptor: | (2R)-2-[2-(1H-indole-3-carbonyl)hydrazinyl]-2-phenylacetamide, GTPase KRas, GUANOSINE-5'-DIPHOSPHATE, ... |  | Authors: | Wang, X,  Gupta, A.K,  Prakash, P,  Putkey, J.P,  Gorfe, A.A. |  | Deposit date: | 2019-12-04 |  | Release date: | 2019-12-18 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR |  | Cite: | Multi target ensemble based virtual screening yields novel allosteric KRAS inhibitors at high success rate Chemical Biology & Drug Design, 94, 2019
 
 | 
 | 
| 6V6T 
   
  |  | 
| 6V88 
   
  |  | 
| 6VA1 
   
  | | Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element |  | Descriptor: | RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3'), RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3') |  | Authors: | Chen, J.L,  Fountain, M.A,  Disney, M.D. |  | Deposit date: | 2019-12-16 |  | Release date: | 2020-05-20 |  | Last modified: | 2024-05-01 |  | Method: | SOLUTION NMR |  | Cite: | Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing. J.Am.Chem.Soc., 142, 2020
 
 | 
 | 
| 6VA2 
   
  | | Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MH5 |  | Descriptor: | (2E,2'E)-2,2'-{dibenzo[b,d]thiene-2,8-diyldi[(1E)eth-1-yl-1-ylidene]}bis(N-methylhydrazine-1-carboximidamide), RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3'), RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3') |  | Authors: | Chen, J.L,  Fountain, M.A,  Disney, M.D. |  | Deposit date: | 2019-12-16 |  | Release date: | 2020-05-20 |  | Last modified: | 2024-05-01 |  | Method: | SOLUTION NMR |  | Cite: | Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing. J.Am.Chem.Soc., 142, 2020
 
 | 
 | 
| 6VA3 
   
  | | Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MQC |  | Descriptor: | 4-[(3-methoxyphenyl)amino]-2-methylquinoline-6-carboximidamide, RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3'), RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3') |  | Authors: | Chen, J.L,  Fountain, M.A,  Disney, M.D. |  | Deposit date: | 2019-12-16 |  | Release date: | 2020-05-20 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR |  | Cite: | Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing. J.Am.Chem.Soc., 142, 2020
 
 | 
 | 
| 6VA4 
   
  | | Solution Structure of the Tau pre-mRNA Exon 10 Splicing Regulatory Element Bound to MIP |  | Descriptor: | N-[3-(8-methoxy-4-oxo-4,5-dihydro-3H-pyrimido[5,4-b]indol-3-yl)propyl]-N-methylcyclohexanaminium, RNA (5'-R(*CP*AP*CP*AP*CP*GP*UP*CP*GP*G)-3'), RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*UP*GP*UP*G)-3') |  | Authors: | Chen, J.L,  Fountain, M.A,  Disney, M.D. |  | Deposit date: | 2019-12-16 |  | Release date: | 2020-05-20 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR |  | Cite: | Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing. J.Am.Chem.Soc., 142, 2020
 
 | 
 | 
| 6VAR 
   
  | | 61 nt human Hepatitis B virus epsilon pre-genomic RNA |  | Descriptor: | RNA (61-MER) |  | Authors: | LeBlanc, R.M,  Kasprzak, W.K,  Longhini, A.P,  Abulwerdi, F,  Ginocchio, S,  Shields, B,  Nyman, J,  Svirydava, M,  Del Vecchio, C,  Ivanic, J,  Schneekloth, J.S,  Dayie, T.K,  Shapiro, B.A,  Le Grice, S.F.J. |  | Deposit date: | 2019-12-17 |  | Release date: | 2020-12-30 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR, SOLUTION SCATTERING |  | Cite: | Structural insights of the conserved "priming loop" of hepatitis B virus pre-genomic RNA. J.Biomol.Struct.Dyn., 2021
 
 | 
 | 
| 6VE9 
   
  |  | 
| 6VED 
   
  | | Solution structure of the TTD and linker region of UHRF1 |  | Descriptor: | E3 ubiquitin-protein ligase UHRF1 |  | Authors: | Lemak, A,  Houliston, S,  Duan, S,  Ong, M.S,  Arrowsmith, C.H. |  | Deposit date: | 2019-12-31 |  | Release date: | 2020-06-17 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR |  | Cite: | Alternative splicing and allosteric regulation modulate the chromatin binding of UHRF1. Nucleic Acids Res., 48, 2020
 
 | 
 | 
| 6VEE 
   
  |  | 
| 6VFO 
   
  | | Solution structure of the PHD of mouse UHRF1 (NP95) |  | Descriptor: | E3 ubiquitin-protein ligase UHRF1, ZINC ION |  | Authors: | Lemak, A,  Houliston, S,  Duan, S,  Arrowsmith, C.H. |  | Deposit date: | 2020-01-06 |  | Release date: | 2020-06-17 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR |  | Cite: | Alternative splicing and allosteric regulation modulate the chromatin binding of UHRF1. Nucleic Acids Res., 48, 2020
 
 | 
 | 
| 6VG7 
   
  |  | 
| 6VGA 
   
  |  | 
| 6VGB 
   
  |  | 
| 6VGT 
   
  |  | 
| 6VH8 
   
  |  | 
| 6VHJ 
   
  |  | 
| 6VJQ 
   
  |  | 
| 6VK2 
   
  |  | 
| 6VL2 
   
  | | Stigmurin |  | Descriptor: | Stigmurin |  | Authors: | Rodrigues, S.C.S,  Resende, J.M,  Araujo, R.M,  Pedrosa, M.F.F. |  | Deposit date: | 2020-01-22 |  | Release date: | 2021-01-13 |  | Last modified: | 2024-11-13 |  | Method: | SOLUTION NMR |  | Cite: | NMR three-dimensional structure of the cationic peptide Stigmurin from Tityus stigmurus scorpion venom: In vitro antioxidant and in vivo antibacterial and healing activity. Peptides, 137, 2021
 
 | 
 | 
| 6VLA 
   
  | | Hs05 - Intragenic antimicrobial peptide |  | Descriptor: | Intragenic antimicrobial peptide |  | Authors: | Santos, M.A,  Silva, E.M.C,  Brand, G.D,  Oliveira, A.L. |  | Deposit date: | 2020-01-23 |  | Release date: | 2020-12-02 |  | Last modified: | 2024-05-15 |  | Method: | SOLUTION NMR |  | Cite: | Characterization of novel human Intragenic Antimicrobial Peptides, incorporation and release studies from ureasil-polyether hybrid matrix Materials Science and Engineering C, Materials for Biological Applications, 119, 2020
 
 | 
 |